Literature DB >> 14747463

The ABCA1 transporter modulates late endocytic trafficking: insights from the correction of the genetic defect in Tangier disease.

Edward B Neufeld1, John A Stonik, Stephen J Demosky, Catherine L Knapper, Christian A Combs, Adele Cooney, Marcella Comly, Nancy Dwyer, Joan Blanchette-Mackie, Alan T Remaley, Silvia Santamarina-Fojo, H Bryan Brewer.   

Abstract

We have previously established that the ABCA1 transporter, which plays a critical role in the lipidation of extracellular apolipoprotein acceptors, traffics between late endocytic vesicles and the cell surface (Neufeld, E. B., Remaley, A. T., Demosky, S. J., Jr., Stonik, J. A., Cooney, A. M., Comly, M., Dwyer, N. K., Zhang, M., Blanchette-Mackie, J., Santamarina-Fojo, S., and Brewer, H. B., Jr. (2001) J. Biol. Chem. 276, 27584-27590). The present study provides evidence that ABCA1 in late endocytic vesicles plays a role in cellular lipid efflux. Late endocytic trafficking was defective in Tangier disease fibroblasts that lack functional ABCA1. Consistent with a late endocytic protein trafficking defect, the hydrophobic amine U18666A retained NPC1 in abnormally tubulated, cholesterol-poor, Tangier disease late endosomes, rather than cholesterol-laden lysosomes, as in wild type fibroblasts. Consistent with a lipid trafficking defect, Tangier disease late endocytic vesicles accumulated both cholesterol and sphingomyelin and were immobilized in a perinuclear localization. The excess cholesterol in Tangier disease late endocytic vesicles retained massive amounts of NPC1, which traffics lysosomal cholesterol to other cellular sites. Exogenous apoA-I abrogated the cholesterol-induced retention of NPC1 in wild type but not in Tangier disease late endosomes. Adenovirally mediated ABCA1-GFP expression in Tangier disease fibroblasts corrected the late endocytic trafficking defects and restored apoA-I-mediated cholesterol efflux. ABCA1-GFP expression in wild type fibroblasts also reduced late endosome-associated NPC1, induced a marked uptake of fluorescent apoA-I into ABCA1-GFP-containing endosomes (that shuttled between late endosomes and the cell surface), and enhanced apoA-I-mediated cholesterol efflux. The combined results of this study suggest that ABCA1 converts pools of late endocytic lipids that retain NPC1 to pools that can associate with endocytosed apoA-I, and be released from the cell as nascent high density lipoprotein.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14747463     DOI: 10.1074/jbc.M314160200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  64 in total

1.  A Short Synthetic Peptide Mimetic of Apolipoprotein A1 Mediates Cholesterol and Globotriaosylceramide Efflux from Fabry Fibroblasts.

Authors:  Ulrike Schueler; Christine Kaneski; Alan Remaley; Stephen Demosky; Nancy Dwyer; Joan Blanchette-Mackie; John Hanover; Roscoe Brady
Journal:  JIMD Rep       Date:  2015-12-19

Review 2.  Regulation of cholesterol homeostasis.

Authors:  Leigh Goedeke; Carlos Fernández-Hernando
Journal:  Cell Mol Life Sci       Date:  2011-10-19       Impact factor: 9.261

Review 3.  The interaction of ApoA-I and ABCA1 triggers signal transduction pathways to mediate efflux of cellular lipids.

Authors:  Guo-Jun Zhao; Kai Yin; Yu-Chang Fu; Chao-Ke Tang
Journal:  Mol Med       Date:  2012-03-27       Impact factor: 6.354

4.  The lipid flux rheostat: implications of lipid trafficking pathways.

Authors:  Gerd Schmitz; Thomas Langmann
Journal:  J Mol Med (Berl)       Date:  2006-02-28       Impact factor: 4.599

Review 5.  The role of vesicular transport in ABCA1-dependent lipid efflux and its connection with NPC pathways.

Authors:  Emmanuel Boadu; Gordon A Francis
Journal:  J Mol Med (Berl)       Date:  2005-11-17       Impact factor: 4.599

6.  Function of the Caenorhabditis elegans ABC transporter PGP-2 in the biogenesis of a lysosome-related fat storage organelle.

Authors:  Lena K Schroeder; Susan Kremer; Maxwell J Kramer; Erin Currie; Elizabeth Kwan; Jennifer L Watts; Andrea L Lawrenson; Greg J Hermann
Journal:  Mol Biol Cell       Date:  2007-01-03       Impact factor: 4.138

7.  Small GTPase ARF6 Regulates Endocytic Pathway Leading to Degradation of ATP-Binding Cassette Transporter A1.

Authors:  Nigora Mukhamedova; Anh Hoang; Huanhuan L Cui; Irena Carmichael; Ying Fu; Michael Bukrinsky; Dmitri Sviridov
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-10-06       Impact factor: 8.311

8.  BIG1, a brefeldin A-inhibited guanine nucleotide-exchange protein modulates ATP-binding cassette transporter A-1 trafficking and function.

Authors:  Sisi Lin; Chun Zhou; Edward Neufeld; Yu-Hua Wang; Suo-Wen Xu; Liang Lu; Ying Wang; Zhi-Ping Liu; Dong Li; Cuixian Li; Shaorui Chen; Kang Le; Heqing Huang; Peiqing Liu; Joel Moss; Martha Vaughan; Xiaoyan Shen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-12-06       Impact factor: 8.311

9.  Selective delipidation of plasma HDL enhances reverse cholesterol transport in vivo.

Authors:  Frank M Sacks; Lawrence L Rudel; Adam Conner; Hassibullah Akeefe; Gerhard Kostner; Talal Baki; George Rothblat; Margarita de la Llera-Moya; Bela Asztalos; Timothy Perlman; Chunyu Zheng; Petar Alaupovic; Jo-Ann B Maltais; H Bryan Brewer
Journal:  J Lipid Res       Date:  2009-01-14       Impact factor: 5.922

10.  V-ATPase (Vacuolar ATPase) Activity Required for ABCA1 (ATP-Binding Cassette Protein A1)-Mediated Cholesterol Efflux.

Authors:  Shuhui Wang Lorkowski; Gregory Brubaker; Kailash Gulshan; Jonathan D Smith
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-11       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.